Jim O’Neill, the acting director of the Centers for Disease Control and Prevention (CDC), has called for significant changes to the measles, mumps, and rubella (MMR) vaccine, advocating for the development of separate monovalent vaccines. This statement marks a notable shift in the CDC’s stance and aligns with the Trump administration’s ongoing criticism of the combined vaccine, which has been a fundamental part of childhood immunization schedules.
O’Neill’s call, made via a post on X, urges vaccine manufacturers to create three distinct vaccines instead of the current combination. While he did not provide specific reasons for this recommendation, the post referenced a message from President Trump advocating for the separation of the MMR vaccine into individual shots administered at different appointments. This proposal raises questions about vaccine efficacy and public health strategies, potentially impacting immunization rates and regulatory discussions in the pharmaceutical industry.
Use the database as your supply chain compass →
